Loading...
XNASLFVN
Market cap282mUSD
Jan 10, Last price  
22.52USD
1D
12.77%
1Q
85.35%
Jan 2017
176.32%
IPO
-4.54%
Name

LifeVantage Corp

Chart & Performance

D1W1MN
XNAS:LFVN chart
P/E
96.04
P/S
1.41
EPS
0.23
Div Yield, %
2.46%
Shrs. gr., 5y
-2.82%
Rev. gr., 5y
-2.40%
Revenues
200m
-6.20%
2,353,7957,165,8195,050,9883,200,1744,141,30411,478,46038,919,223126,182,848208,178,000213,968,000190,336,000206,540,000199,489,000203,204,000225,958,000232,915,000220,181,000206,360,000213,398,000200,164,000
Net income
3m
+15.63%
-5,822,397-2,734,501-3,693,578-2,054,439-9,114,634-11,048,328-50,791,75012,469,0777,608,00011,383,0006,987,0006,019,0001,608,0005,761,0007,429,00011,549,00012,894,0003,120,0002,540,0002,937,000
CFO
12m
+78.63%
-2,912,977-915,629-3,128,090-747,777-5,206,904-4,499,4834,680,92519,388,94810,662,00012,105,00013,221,0005,986,0006,597,00013,256,00017,789,00018,326,00016,273,0007,959,0006,828,00012,197,000
Dividend
Sep 09, 20240.04 USD/sh
Earnings
Jan 28, 2025

Profile

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.
IPO date
Sep 12, 2012
Employees
248
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
200,164
-6.20%
213,398
3.41%
206,360
-6.28%
Cost of revenue
195,832
209,739
199,485
Unusual Expense (Income)
NOPBT
4,332
3,659
6,875
NOPBT Margin
2.16%
1.71%
3.33%
Operating Taxes
1,413
1,459
1,571
Tax Rate
32.62%
39.87%
22.85%
NOPAT
2,919
2,200
5,304
Net income
2,937
15.63%
2,540
-18.59%
3,120
-75.80%
Dividends
(6,940)
(1,586)
(378)
Dividend yield
8.32%
2.90%
0.66%
Proceeds from repurchase of equity
(7,380)
(570)
(8,707)
BB yield
8.85%
1.04%
15.32%
Debt
Debt current
3,622
3,042
2,601
Long-term debt
25,413
36,219
28,909
Deferred revenue
Other long-term liabilities
198
(11,267)
308
Net debt
12,149
17,656
11,320
Cash flow
Cash from operating activities
12,197
6,828
7,959
CAPEX
(2,245)
(3,067)
(1,530)
Cash from investing activities
(2,245)
(3,059)
(1,530)
Cash from financing activities
(14,417)
(2,357)
(8,952)
FCF
6,670
2,466
6,027
Balance
Cash
16,886
21,605
20,190
Long term investments
Excess cash
6,878
10,935
9,872
Stockholders' equity
(110,653)
(99,665)
(99,559)
Invested Capital
152,265
149,221
146,685
ROIC
1.94%
1.49%
3.61%
ROCE
10.41%
7.38%
14.59%
EV
Common stock shares outstanding
12,986
12,567
13,069
Price
6.42
47.59%
4.35
0.00%
4.35
-40.82%
Market cap
83,370
52.51%
54,666
-3.84%
56,850
-45.79%
EV
95,519
72,322
68,170
EBITDA
7,913
7,238
11,922
EV/EBITDA
12.07
9.99
5.72
Interest
198
10
Interest/NOPBT
5.41%
0.15%